Personal Information:
 |
Email:
tlg232@psu.edu, tgilman@vt.edu Program: Neuroscience Ph.D. program (Fall 2007-present) Education: Virginia Polytechnic Institute and State University May 2006, Psychology, Minor in Chemistry, Summa Cum Laude May 2005, Animal and Poultry Sciences, Minor in Russian, Summa Cum Laude Previous research experience: NIH Postbaccalaureate IRTA Fellow, NIAAA, Rockville, MD (June 2006-June 2007): Efficacy of viral and non-viral vectors on neuronal transfection in mice after stereotaxic injection; Characterization of protein expression in cerebellum following DNA damage in mice Pharmacology Research Assistant, Virginia College of Osteopathic Medicine, Blacksburg, VA (May 2005-June 2006): Involvement of neurotransmitter release in mediating hyperthermic effects of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) |
Current projects:In addition to assisting Drs. Anne Andrews and Beth Luellen on an invited book chapter concerning changes in neurotransmitter levels in response to alterations of serotonin (5-HT) transporter (SERT, 5-HTT) functioning, I am also working on developing two research projects. One entails altering serotonin (5-HT) levels during development, while the other involves changing SERT expression at different points during the lifespan.
Peer-reviewed publications:
- Sprague JE, Yang X, Sommers J, Gilman TL, Mills EM (2007) Roles of norepinephrine, free fatty acids, thyroid status and skeletal muscle uncoupling protein 3 expression in sympathomimetic-induced thermogenesis. J Pharmacol Exp Ther 320(1):274-280.
- Gilman TL, Haden SC (2006) Understanding and treating the juvenile firesetter: A review. The Forensic Examiner 15(4):11-18.
- Peterson AL, Gilman TL, Banks ML, Sprague JE (2006) Hypothyroidism alters striatal dopamine release mediated by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy). Synapse 59(5):317-319.
